Churg-Strauss Syndrome: all 61 studies

Page 1 of 1. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Benralizumab Effectiveness in EGPARecruitingNCT07815886
• Ocular Manifestations of Granulomatosis With Polyangiitis.RecruitingNCT07664709
• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruitingNCT07444567Phase 3
• Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPAEnrolling by invitationNCT07343661Phase 4
• The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic SyndromeRecruitingNCT07275190Not applicable
• Eosinophil Subpopulations in Eosinophilic-associated DiseasesNot yet recruitingNCT06911775
• A Trial to Investigate Benralizumab in Children With Eosinophilic DiseasesRecruitingNCT06512883Phase 3
• eGPA and Local Inflammation Within the Ear, Nose and Throat AreaRecruitingNCT06298448
• The Epigenomic Signature of Eosinophilic Granulomatosis With PolyangiitisNot yet recruitingNCT06231498
• A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）RecruitingNCT05979051Phase 2/3
• Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing EosinophilsRecruitingNCT04538937
• Clinical Transcriptomics in Systemic Vasculitis (CUTIS)RecruitingNCT03004326
• VCRC Tissue RepositoryRecruitingNCT02967068
• Vasculitis Pregnancy RegistryRecruitingNCT02593565
• Pediatric Vasculitis InitiativeRecruitingNCT02006134
• One-Time DNA Study for VasculitisRecruitingNCT01241305
• Longitudinal Study for Eosinophilic Granulomatosis With PolyangiitisRecruitingNCT00315380
• Identification of Autoantigens in EGPA and Severe Eosinophilic AsthmaCompletedNCT04671446Results posted
• Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in JapanCompletedNCT04551989Results posted
• Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.Active, not recruitingNCT04157348Phase 3Results posted
• NUCALA® Special Drug Use Investigation (EGPA, Long-term)CompletedNCT03557060Results posted
• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921CompletedNCT03298061Phase 3Results posted
• A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisCompletedNCT02020889Phase 3Results posted
• Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss SyndromeCompletedNCT00527566Phase 1/2Results posted
• Rituxan in Churg Strauss Syndrome With Renal InvolvementTerminatedNCT00424749Phase 2Results posted
• Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300CompletedNCT07592104
• Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)CompletedNCT07591753
• Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple IndicationsCompletedNCT06488703
• Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With PolyangiitisActive, not recruitingNCT06230354Phase 2
• Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With PolyangiitisActive, not recruitingNCT06046222Phase 2
• An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/2
• Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)Active, not recruitingNCT05263934Phase 3
• FASENRA Regulatory Postmarketing Surveillance in KoreaCompletedNCT05091333
• Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)CompletedNCT05030155Phase 3
• Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated GlomerulonephritisCompletedNCT04428398
• Urinary T Cell Biomarker for Prediction in ANCA GlomerulonephritisStatus unknownNCT04320667
• Hydroxychloroquine in ANCA Vasculitis EvaluationTerminatedNCT04316494Phase 4
• PRagmatic Analysis of Vitamin D in ANCA-Associated VasculitisCompletedNCT04280601Not applicable
• Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated VasculitisCompletedNCT03698071Not applicable
• Low Dose Naltrexone to Improve Physical Health in Patients With VasculitisCompletedNCT03482479Phase 2
• Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT03410290
• Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.CompletedNCT03164473Phase 3
• Eosinophilic Granulomatosis With Polyangiitis CohortCompletedNCT03036670
• Rituximab in Eosinophilic Granulomatosis With PolyangiitisCompletedNCT02807103Phase 3
• Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss SyndromeTerminatedNCT02728271Early Phase 1
• The ANCA Vasculitis Questionnaire (AAV-PRO©)CompletedNCT02507024
• VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT02190942
• Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
• Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
• Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
• PRO Development for ANCA Associated VasculitisStatus unknownNCT01729624
• American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT01066208
• Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesStatus unknownNCT00751517Phase 2
• Safety and Efficacy Study of Mepolizumab in Churg Strauss SyndromeCompletedNCT00716651Phase 2
• Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
• Abatacept in ANCA Associated VasculitisTerminatedNCT00482066Phase 2
• CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis FactorsStatus unknownNCT00399399Phase 4
• Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing VasculitidesCompletedNCT00307593Not applicable
• Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic SyndromeCompletedNCT00266565Phase 1/2
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable

← Churg-Strauss Syndrome overview